Vifor Pharma UK Limited is a registered limited company operating within the UK pharmaceutical sector. Established in 2008, Vifor Pharma UK Limited is currently active and maintains a Reg: 06514784 status. The company’s registered address is 5 New Street Square, London, EC4A 3TW. Vifor Pharma UK Limited specializes in the wholesale distribution of pharmaceutical goods, primarily focused on the IV administration of Venofer. Venofer is a vital iron sucrose product utilized for the treatment of iron deficiency in chronic kidney disease, where oral therapies are insufficient. The company’s core services encompass sourcing, packaging, and distribution of pharmaceutical products to healthcare professionals and institutions. Vifor Pharma UK Limited’s international presence is currently non-existent. As a limited company, Vifor Pharma UK Limited is classified as a ‘type’ and operates within the ‘pharmaceutical goods’ SIC code. The company’s size estimate is considered ‘small’ based on its operational scope. The complainant’s account highlights a potential conflict of interest surrounding the promotion of Venofer through the PIVOTAL study, suggesting a possible connection to the product’s use. The company is currently rated as a ‘worker’ with a ‘A’ rating, indicating a focus on compliance and operational efficiency.

Vifor Pharma UK Limited is a registered limited company operating within the UK pharmaceutical sector. Established in 2008, Vifor Pharma UK Limited is currently active and maintains a Reg: 06514784 status. The company’s registered address is 5 New Street Square, London, EC4A 3TW. Vifor Pharma UK Limited specializes in the wholesale distribution of pharmaceutical goods, primarily focused on the IV administration of Venofer. Venofer is a vital iron sucrose product utilized for the treatment of iron deficiency in chronic kidney disease, where oral therapies are insufficient. The company’s core services encompass sourcing, packaging, and distribution of pharmaceutical products to healthcare professionals and institutions. Vifor Pharma UK Limited’s international presence is currently non-existent. As a limited company, Vifor Pharma UK Limited is classified as a ‘type’ and operates within the ‘pharmaceutical goods’ SIC code. The company’s size estimate is considered ‘small’ based on its operational scope. The complainant’s account highlights a potential conflict of interest surrounding the promotion of Venofer through the PIVOTAL study, suggesting a possible connection to the product’s use. The company is currently rated as a ‘worker’ with a ‘A’ rating, indicating a focus on compliance and operational efficiency.